Publications by authors named "C S Hulton"

Article Synopsis
  • The study explores the role of the mitogen-activated protein kinase (MAPK) pathway in small cell lung cancer (SCLC), highlighting its unique behavior compared to non-small cell lung cancer.
  • It reveals that the most common subtype, SCLC-A, is sensitive to MAPK activation, which induces cell-cycle arrest and senescence.
  • The research also identifies significant changes in regulatory pathways upon MAPK activation, suggesting that SCLC has complex signaling networks and subtype-specific vulnerabilities that could be targeted for treatment.
View Article and Find Full Text PDF

Patient-derived xenografts are high fidelity tumor models that accurately reflect many key aspects of human cancer. In contrast to either cancer cell lines or genetically engineered mouse models, the utility of PDXs has been limited by the inability to perform targeted genome editing of these tumors. To address this limitation, we have developed methods for CRISPR-Cas9 editing of PDXs using a tightly regulated, inducible Cas9 vector that does not require culture for selection of transduced cells.

View Article and Find Full Text PDF

Concurrent loss-of-function mutations in STK11 and KEAP1 in lung adenocarcinoma (LUAD) are associated with aggressive tumor growth, resistance to available therapies, and early death. We investigated the effects of coordinate STK11 and KEAP1 loss by comparing co-mutant with single mutant and wild-type isogenic counterparts in multiple LUAD models. STK11/KEAP1 co-mutation results in significantly elevated expression of ferroptosis-protective genes, including SCD and AKR1C1/2/3, and resistance to pharmacologically induced ferroptosis.

View Article and Find Full Text PDF

Unlabelled: TBK1 (TANK-binding kinase 1) is a noncanonical IκB protein kinase that phosphorylates and activates downstream targets such as IRF3 and c-Rel and, mediates NF-κB activation in cancer. Previous reports demonstrated synthetic lethality of TBK1 with mutant KRAS in non-small cell lung cancer (NSCLC); thus, TBK1 could be a novel target for treatment of KRAS-mutant NSCLC. Here, the effect of TBK1 on proliferation in a panel of cancer cells by both genetic and pharmacologic approaches was evaluated.

View Article and Find Full Text PDF

Transcription from many bacterial promoters is sensitive to the level of DNA supercoiling. We have investigated the mechanism by which environmentally induced changes in DNA supercoiling might regulate transcription. For the proU promoter of Salmonella typhimurium, osmotically induced changes in DNA topology appear to play a primary regulatory role.

View Article and Find Full Text PDF